Options
Cost-effective treatment with half year of trastuzumab and chemotherapy as adjuvant treatment for overexpression of Her2/neu breast cancer patients: Two institutional experiences in Taiwan
Type
conference
Resource
J. CLIN ONCOL
Date Issued
2006
Author(s)
吳志雄
Tai CJ; Pan CK; Wu CH; Chen CS; ;
Subjects
外科學科
會議論文